Cantitate/Preț
Produs

Clinical, Biological and Molecular Aspects of COVID-19: Advances in Experimental Medicine and Biology, cartea 1321

Editat de Paul C. Guest
en Limba Engleză Hardback – 4 mar 2021
The novel coronavirus 2019 (COVID-19) has caused a serious global pandemic in just eight months. Nearly every country and territory in the world has been affected by the virus. The virulence and infection rate of the virus are profound, and has required extreme social distancing measures across the globe in order to prevent overwhelming the healthcare services and hospitals. COVID-19 appears to have the greatest effects on elderly individuals and those who have co-morbid diseases, such as heart disease, asthma, and diabetes. As the peak begins to slow in many countries, the death rates remain high amidst justified fears of a second wave. A rapid worldwide mobilization has begun to identify effective treatments and develop vaccines.
This new volume will increase readers’ understanding of the ongoing COVID-19 pandemic through a series of chapters that address these concerns. Leading experts will discuss the effects of the virus in cases of co-morbidities, new treatment approaches, mental health aspects of the pandemic, and convey the results of survey studies. The book will be an excellent resource for researchers studying virology, metabolic diseases, respiratory disorders, and clinical scientists, physicians, drug companies, and healthcare services and workers.
Citește tot Restrânge

Din seria Advances in Experimental Medicine and Biology

Preț: 37458 lei

Preț vechi: 79697 lei
-53%

Puncte Express: 562

Preț estimativ în valută:
7168 7744$ 6142£

Carte în stoc

Livrare din stoc 23 februarie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783030592608
ISBN-10: 303059260X
Ilustrații: XVII, 353 p. 53 illus., 37 illus. in color.
Dimensiuni: 178 x 254 mm
Greutate: 0.9 kg
Ediția:1st ed. 2021
Editura: Springer International Publishing
Colecția Springer
Seriile Advances in Experimental Medicine and Biology, Proteomics, Metabolomics, Interactomics and Systems Biology

Locul publicării:Cham, Switzerland

Cuprins

1.SARS-CoV-2 (COVID-19): Beginning to Understand a New Virus
2.Neurological Complications of the COVID-19 Pandemic: What have we got so Far? 
3.Endothelial Dysfunction as a Primary Consequence of SARS-CoV-2 Infection 
4.A Review Study on the Neonatal Outcomes of Pregnant Women with COVID-19
5.Relationship between COVID-19 and Angiotensin-Converting Enzyme 2: A Scoping Review
6.Experience in Nutrition Management of Diabetes-affected COVID-19 Patients
7.Emerging Technologies for the Treatment of COVID-19
8.Obesity and risk of COVID-19 infection and severity: available evidence and mechanisms
9.COVID-19 is an Endothelial Disease: Implications of Nitric Oxide
10.Immune Response and Effectiveness of COVID-19 Therapies
11.The Novel Coronavirus and Inflammation
12.Does SARS-CoV-2 Threaten Male Fertility?
13.COVID-19 and Vulnerable Populations in Sub-Saharan Africa: a Review 
14.Overview of the Haematological Effects of COVID-19 Infection 
15.The Novel Coronavirus and Haemostatic Abnormalities: Pathophysiology, Clinical Manifestations and Treatment Recommendations
16.COVID-19 related laboratory analyte changes and the relationship between SARS-CoV-2 and HIV, TB and HbA1c in South Africa 
17.The Primary Outcomes, Epidemiological and Clinical Features of Coronavirus Disease-2019 (COVID-19) in Iran 
18.Acute Respiratory Distress Syndrome and COVID-19: A Scoping Review and Meta-Analysis
19.Depression, Anxiety and Stress Among Patients with COVID-19: A Cross-sectional Study
20.Survey of Immediate Psychological Distress Levels among Health Care Workers in the COVID-19 Epidemic: A Cross-sectional Study
21.Coronavirus (COVID-19)-Associated Psychological Distress Among Medical Students in Iran
22.A Survey of Psychological Distress among the Community in the COVID-19 Epidemic: A Cross-Sectional Study
23.Gender Susceptibility to COVID-19 Mortality: Androgens as the Usual Suspects?
24.Identification, Monitoring and Prediction of Disease Severity in Patients with COVID-19 Pneumonia Based on Chest Computed Tomography Scans: a Retrospective Study  
25.The Level of Procalcitonin in Severe COVID-19 Patients: A Systematic Review and Meta-analysis
26.A Systematic Review of 571 Pregnancies Affected by COVID-19
27.The 2019 Novel Coronavirus Disease in Pregnancy: A Systematic Review
28.Acute Kidney Injury and Covid-19: a Scoping Review and Meta-analysis
29.Cardiac Injury in COVID-19: A Systematic Review
30.A Systematic Review of the Assessment of the Presence of SARS-CoV-2 in Human Semen
Index

Notă biografică

Dr. Paul C. Guest, Ph.D, is a scientific researcher/writer with 37 years of experience in the fields of metabolic and neurological disorders. This includes experience in both academia and the pharmaceutical industry with the majority of time spent at the University of Cambridge and Merck Sharp & Dohme in the United Kingdom. He has also been affiliated with the University of Campinas in Sao Paulo Brazil since 2015, still focused on advancing the field of biomarkers for neurological disorders such as schizophrenia and Alzheimer’s disease, and more recently in the area of anti-aging research.

Textul de pe ultima copertă

The novel coronavirus 2019 (COVID-19) has caused a serious global pandemic in just eight months. Nearly every country and territory in the world has been affected by the virus. The virulence and infection rate of the virus are profound, and has required extreme social distancing measures across the globe in order to prevent overwhelming the healthcare services and hospitals. COVID-19 appears to have the greatest effects on elderly individuals and those who have co-morbid diseases, such as heart disease, asthma, and diabetes. As the peak begins to slow in many countries, the death rates remain high amidst justified fears of a second wave. A rapid worldwide mobilization has begun to identify effective treatments and develop vaccines.
This new volume will increase readers’ understanding of the ongoing COVID-19 pandemic through a series of chapters that address these concerns. Leading experts will discuss the effects of the virus in cases of co-morbidities, new treatment approaches, mental health aspects of the pandemic, and convey the results of survey studies. The book will be an excellent resource for researchers studying virology, metabolic diseases, respiratory disorders, and clinical scientists, physicians, drug companies, and healthcare services and workers.

Caracteristici

Addresses the current global pandemic and increases understanding of current challenges
Discusses effects of COVID-19 on individuals with co-morbid diseases and gives insights into potential treatments
Provides results of cross-sectional survey studies from different COVID-19-impacted communities
Gives insights which may help us to address future pandemics more effectively